Petros Pharmaceuticals, Inc. (PTPI)
NASDAQ: PTPI · Real-Time Price · USD
0.0840
+0.0149 (21.56%)
At close: Apr 1, 2025, 4:00 PM
0.0701
-0.0139 (-16.55%)
After-hours: Apr 1, 2025, 7:59 PM EDT

Petros Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2023FY 2022FY 2021FY 2020FY 2019 2018
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018
Revenue
4.025.825.997.819.5615.58
Upgrade
Revenue Growth (YoY)
-42.41%-2.83%-23.29%-18.29%-38.63%10.86%
Upgrade
Cost of Revenue
1.111.632.291.64.057.43
Upgrade
Gross Profit
2.924.193.76.215.518.15
Upgrade
Selling, General & Admin
10.189.2612.2115.5915.6719.73
Upgrade
Research & Development
3.352.411.741.790.46-
Upgrade
Operating Expenses
16.514.9519.5524.2622.825.02
Upgrade
Operating Income
-13.59-10.76-15.85-18.05-17.28-16.87
Upgrade
Interest Expense
-0.52-0.54-0.6-0.37-3.05-13.84
Upgrade
Interest & Investment Income
0.570.520.01---
Upgrade
Other Non Operating Income (Expenses)
6.220.03---1.68-
Upgrade
EBT Excluding Unusual Items
-7.32-10.75-16.43-18.42-22.01-30.71
Upgrade
Impairment of Goodwill
------2.44
Upgrade
Asset Writedown
---7.46---
Upgrade
Other Unusual Items
2.592.593.859.43--
Upgrade
Pretax Income
-4.73-8.16-20.04-8.99-22.01-33.16
Upgrade
Income Tax Expense
-----1.43-0.65
Upgrade
Net Income
-4.73-8.16-20.04-8.99-20.59-32.51
Upgrade
Preferred Dividends & Other Adjustments
15.125.65----
Upgrade
Net Income to Common
-19.85-13.81-20.04-8.99-20.59-32.51
Upgrade
Shares Outstanding (Basic)
622110
Upgrade
Shares Outstanding (Diluted)
622110
Upgrade
Shares Change (YoY)
190.11%5.11%90.11%103.90%117.10%146.00%
Upgrade
EPS (Basic)
-3.26-6.35-9.68-8.25-38.55-132.16
Upgrade
EPS (Diluted)
-3.26-6.35-9.68-8.25-38.55-132.16
Upgrade
Free Cash Flow
-5.85-7.63-12.8-11.86-15.312.46
Upgrade
Free Cash Flow Per Share
-0.96-3.50-6.18-10.89-28.6710.00
Upgrade
Gross Margin
72.50%71.98%61.79%79.52%57.67%52.32%
Upgrade
Operating Margin
-337.80%-184.84%-264.44%-231.05%-180.78%-108.29%
Upgrade
Profit Margin
-493.45%-237.26%-334.40%-115.05%-215.35%-208.71%
Upgrade
Free Cash Flow Margin
-145.37%-130.99%-213.57%-151.86%-160.16%15.80%
Upgrade
EBITDA
-10.61-7.48-10.25-11.17-10.62-11.58
Upgrade
EBITDA Margin
-263.77%-128.46%-171.01%-143.00%-111.11%-74.32%
Upgrade
D&A For EBITDA
2.983.285.66.886.665.29
Upgrade
EBIT
-13.59-10.76-15.85-18.05-17.28-16.87
Upgrade
EBIT Margin
--184.84%-264.44%-231.05%-180.78%-108.29%
Upgrade
Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q